Want to see HK:2591 full AI Analyst Report?

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H (2591) Revenue

0 Followers

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Revenue

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H had a revenue of 77.14M in the quarter ending Jun 30, 2026, with 4.51%. This bring the company's revenue in the last twelve months to 150.95M, Decreased 16.91%. In the fiscal year ending Dec 31, 2025, Guangzhou Innogen Pharmaceutical Group Co Ltd Class H had annual revenue of 128.11M with Infinity% growth.

Revenue (ttm)

150.95M

Revenue Growth

182.60%

P/S Ratio

13.30

Revenue/Employee

HK$663,759

Employees

193

Market Cap

HK$1.70B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	128.11M	―	+∞%
Dec 31, 2024	―	―	―
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―